(51 of 54) remained free from the burden of continuous prophylaxis treatment through five years following a single infusion of HEMGENIX, demonstrating sustained therapeutic benefit- At year five, mean ...
The Indiana Chamber's Coolest Thing Made IN Indiana tournament has narrowed from 49 to 32 competitors, with the second round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback